HEADER IMMUNE SYSTEM 16-DEC-11 4ACP TITLE DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IMMUNOGLOBULIN GAMMA, FC, RESIDUES 101-329; COMPND 5 SYNONYM: HUMAN IG GAMMA-1 CHAIN C REGION; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: 293T; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: 293T; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1573; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS IMMUNE SYSTEM, IGG, ANTIBODY, KIFUNENSINE EXPDTA X-RAY DIFFRACTION AUTHOR K.RAMAN,T.A.BOWDEN,B.A.KRISHNA,R.A.DWEK,M.CRISPIN,C.N.SCANLAN REVDAT 4 20-DEC-23 4ACP 1 HETSYN REVDAT 3 29-JUL-20 4ACP 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 13-JUN-12 4ACP 1 JRNL REVDAT 1 25-APR-12 4ACP 0 JRNL AUTH K.BARUAH,T.A.BOWDEN,B.A.KRISHNA,R.A DWEK,M.CRISPIN, JRNL AUTH 2 C.N.SCANLAN JRNL TITL SELECTIVE DEACTIVATION OF SERUM IGG: A GENERAL STRATEGY FOR JRNL TITL 2 THE ENHANCEMENT OF MONOCLONAL ANTIBODY RECEPTOR JRNL TITL 3 INTERACTIONS. JRNL REF J.MOL.BIOL. V. 420 1 2012 JRNL REFN ISSN 0022-2836 JRNL PMID 22484364 JRNL DOI 10.1016/J.JMB.2012.04.002 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 18408 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 980 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1290 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.68 REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 25 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.49000 REMARK 3 B22 (A**2) : -2.81000 REMARK 3 B33 (A**2) : 3.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.72000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.392 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.252 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.212 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 20.809 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3358 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2301 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4569 ; 1.238 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5638 ; 0.778 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 401 ; 6.180 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 148 ;35.283 ;24.932 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 570 ;15.832 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;20.922 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 506 ; 0.069 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3633 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 631 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 341 A 444 5 REMARK 3 1 B 341 B 444 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 611 ; 0.16 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 611 ; 0.16 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 795 ; 0.55 ; 5.00 REMARK 3 LOOSE POSITIONAL 1 B (A): 795 ; 0.55 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 611 ; 3.34 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 611 ; 3.34 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 795 ; 3.94 ; 10.00 REMARK 3 LOOSE THERMAL 1 B (A**2): 795 ; 3.94 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 236 A 339 REMARK 3 ORIGIN FOR THE GROUP (A): -33.3430 -4.6490 32.0330 REMARK 3 T TENSOR REMARK 3 T11: 0.2675 T22: 0.2955 REMARK 3 T33: 0.8726 T12: 0.0716 REMARK 3 T13: 0.2022 T23: 0.0090 REMARK 3 L TENSOR REMARK 3 L11: 2.5142 L22: 6.2500 REMARK 3 L33: 5.6327 L12: -1.6642 REMARK 3 L13: -0.6142 L23: -0.2443 REMARK 3 S TENSOR REMARK 3 S11: 0.0265 S12: -0.3172 S13: 0.8184 REMARK 3 S21: 0.6076 S22: -0.2913 S23: -0.7191 REMARK 3 S31: -0.1234 S32: 0.1039 S33: 0.2648 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 236 B 339 REMARK 3 ORIGIN FOR THE GROUP (A): -11.4790 8.4680 10.0540 REMARK 3 T TENSOR REMARK 3 T11: 0.1938 T22: 0.1010 REMARK 3 T33: 0.2017 T12: 0.0932 REMARK 3 T13: -0.0045 T23: 0.0704 REMARK 3 L TENSOR REMARK 3 L11: 5.0048 L22: 7.0747 REMARK 3 L33: 3.1300 L12: -4.0390 REMARK 3 L13: 0.0125 L23: -0.7174 REMARK 3 S TENSOR REMARK 3 S11: -0.2738 S12: -0.3602 S13: 0.2200 REMARK 3 S21: 0.7522 S22: 0.5484 S23: -0.0658 REMARK 3 S31: -0.5620 S32: -0.4074 S33: -0.2746 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 340 A 444 REMARK 3 ORIGIN FOR THE GROUP (A): -19.0120 -28.8270 22.1030 REMARK 3 T TENSOR REMARK 3 T11: 0.2529 T22: 0.0668 REMARK 3 T33: 0.2506 T12: -0.0491 REMARK 3 T13: 0.0591 T23: -0.0097 REMARK 3 L TENSOR REMARK 3 L11: 5.4410 L22: 3.3121 REMARK 3 L33: 3.7637 L12: 0.4342 REMARK 3 L13: -0.3757 L23: -0.3784 REMARK 3 S TENSOR REMARK 3 S11: -0.0443 S12: -0.4790 S13: 0.0219 REMARK 3 S21: 0.5256 S22: -0.0707 S23: 0.5218 REMARK 3 S31: 0.3356 S32: -0.2465 S33: 0.1149 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 340 B 444 REMARK 3 ORIGIN FOR THE GROUP (A): -10.1100 -24.1210 8.9080 REMARK 3 T TENSOR REMARK 3 T11: 0.1405 T22: 0.0197 REMARK 3 T33: 0.1813 T12: 0.0202 REMARK 3 T13: -0.0995 T23: 0.0060 REMARK 3 L TENSOR REMARK 3 L11: 4.2951 L22: 4.8514 REMARK 3 L33: 2.1727 L12: 2.3525 REMARK 3 L13: 0.2143 L23: 0.7212 REMARK 3 S TENSOR REMARK 3 S11: -0.2866 S12: 0.1058 S13: 0.0533 REMARK 3 S21: 0.0312 S22: 0.1751 S23: 0.1903 REMARK 3 S31: 0.0821 S32: -0.0147 S33: 0.1115 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4ACP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1290050699. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19399 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 34.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 8.400 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2DTQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% W/V POLYETHYLENE GLYCOL 1500, 0.1 REMARK 280 M SPG SYSTEM BUFFER PH 4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.64500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.42850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.64500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 55.42850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2004 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 216 REMARK 465 THR A 217 REMARK 465 LYS A 218 REMARK 465 SER A 219 REMARK 465 CYS A 220 REMARK 465 ASP A 221 REMARK 465 LYS A 222 REMARK 465 THR A 223 REMARK 465 HIS A 224 REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 230 REMARK 465 ALA A 231 REMARK 465 PRO A 232 REMARK 465 GLU A 233 REMARK 465 LEU A 234 REMARK 465 LEU A 235 REMARK 465 GLY A 236 REMARK 465 GLY A 237 REMARK 465 GLU A 269 REMARK 465 ASP A 270 REMARK 465 TYR A 296 REMARK 465 ASN A 297 REMARK 465 SER A 298 REMARK 465 ALA A 327 REMARK 465 LEU A 328 REMARK 465 PRO A 329 REMARK 465 ALA A 330 REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 GLY A 447 REMARK 465 THR A 448 REMARK 465 LYS A 449 REMARK 465 HIS A 450 REMARK 465 HIS A 451 REMARK 465 HIS A 452 REMARK 465 HIS A 453 REMARK 465 HIS A 454 REMARK 465 HIS A 455 REMARK 465 GLY B 216 REMARK 465 THR B 217 REMARK 465 LYS B 218 REMARK 465 SER B 219 REMARK 465 CYS B 220 REMARK 465 ASP B 221 REMARK 465 LYS B 222 REMARK 465 THR B 223 REMARK 465 HIS B 224 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 230 REMARK 465 ALA B 231 REMARK 465 PRO B 232 REMARK 465 GLU B 233 REMARK 465 LEU B 234 REMARK 465 LEU B 235 REMARK 465 GLY B 236 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 GLY B 447 REMARK 465 THR B 448 REMARK 465 LYS B 449 REMARK 465 HIS B 450 REMARK 465 HIS B 451 REMARK 465 HIS B 452 REMARK 465 HIS B 453 REMARK 465 HIS B 454 REMARK 465 HIS B 455 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 337 148.72 -175.52 REMARK 500 HIS A 435 29.39 46.18 REMARK 500 TYR B 296 2.51 -65.84 REMARK 500 ASN B 297 30.57 -85.71 REMARK 500 PRO B 374 -172.43 -69.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 ( ORTHORHOMBIC) REMARK 900 RELATED ID: 1E4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC -GAMMA REMARK 900 RECEPTOR III COMPLEX REMARK 900 RELATED ID: 1H3U RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1OQX RELATED DB: PDB REMARK 900 G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSIONOF REMARK 900 PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1H3V RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1FC1 RELATED DB: PDB REMARK 900 FC FRAGMENT (IGG1 CLASS) REMARK 900 RELATED ID: 2WAH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2) REMARK 900 RELATED ID: 1AQK RELATED DB: PDB REMARK 900 THREE-DIMENSIONAL STRUCTURE OF A HUMAN FAB WITH HIGH AFFINITY FOR REMARK 900 TETANUS TOXOID REMARK 900 RELATED ID: 2RCS RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB - AFFINITY MATURATION OF AN REMARK 900 ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1D5I RELATED DB: PDB REMARK 900 UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 1D5B RELATED DB: PDB REMARK 900 UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY REMARK 900 RELATED ID: 2IWG RELATED DB: PDB REMARK 900 COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC REMARK 900 RELATED ID: 2J6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM REMARK 900 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND REMARK 900 EVIDENCE FOR AFFINITY MATURATION REMARK 900 RELATED ID: 1I7Z RELATED DB: PDB REMARK 900 ANTIBODY GNC92H2 BOUND TO LIGAND REMARK 900 RELATED ID: 1H3Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALTCONDITION REMARK 900 RELATED ID: 1D6V RELATED DB: PDB REMARK 900 CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE REMARK 900 ANTIBODY MATURATION REMARK 900 RELATED ID: 1FCC RELATED DB: PDB REMARK 900 RELATED ID: 1H3W RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1DN2 RELATED DB: PDB REMARK 900 FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE REMARK 900 PEPTIDE DCAWHLGELVWCT-NH2 REMARK 900 RELATED ID: 1H3T RELATED DB: PDB REMARK 900 STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A REMARK 900 CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY REMARK 900 RELATED ID: 1T89 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR INCOMPLEX REMARK 900 WITH AN FC FRAGMENT OF IGG1 ( HEXAGONAL) REMARK 900 RELATED ID: 1FC2 RELATED DB: PDB REMARK 900 RELATED ID: 1AJ7 RELATED DB: PDB REMARK 900 IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5- REMARK 900 (PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION REMARK 900 OF AN ESTEROLYTIC ANTIBODY REMARK 900 RELATED ID: 1L6X RELATED DB: PDB REMARK 900 FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OFTHE B- REMARK 900 DOMAIN FROM PROTEIN A CALLED Z34C REMARK 900 RELATED ID: 1BEY RELATED DB: PDB REMARK 900 ANTIBODY TO CAMPATH-1H HUMANIZED FAB REMARK 999 REMARK 999 SEQUENCE REMARK 999 T393A MUTATION AROSE DURING CLONING DBREF 4ACP A 218 446 UNP P01857 IGHG1_HUMAN 101 329 DBREF 4ACP B 218 446 UNP P01857 IGHG1_HUMAN 101 329 SEQADV 4ACP GLY A 216 UNP P01857 EXPRESSION TAG SEQADV 4ACP THR A 217 UNP P01857 EXPRESSION TAG SEQADV 4ACP GLY A 447 UNP P01857 EXPRESSION TAG SEQADV 4ACP THR A 448 UNP P01857 EXPRESSION TAG SEQADV 4ACP LYS A 449 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 450 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 451 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 452 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 453 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 454 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS A 455 UNP P01857 EXPRESSION TAG SEQADV 4ACP ALA A 393 UNP P01857 THR 276 CLONING ARTIFACT SEQADV 4ACP GLY B 216 UNP P01857 EXPRESSION TAG SEQADV 4ACP THR B 217 UNP P01857 EXPRESSION TAG SEQADV 4ACP GLY B 447 UNP P01857 EXPRESSION TAG SEQADV 4ACP THR B 448 UNP P01857 EXPRESSION TAG SEQADV 4ACP LYS B 449 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 450 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 451 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 452 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 453 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 454 UNP P01857 EXPRESSION TAG SEQADV 4ACP HIS B 455 UNP P01857 EXPRESSION TAG SEQADV 4ACP ALA B 393 UNP P01857 THR 276 CLONING ARTIFACT SEQRES 1 A 240 GLY THR LYS SER CYS ASP LYS THR HIS THR CYS PRO PRO SEQRES 2 A 240 CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE SEQRES 3 A 240 LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER SEQRES 4 A 240 ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER SEQRES 5 A 240 HIS GLU ASP PRO GLU VAL LYS PHE ASN TRP TYR VAL ASP SEQRES 6 A 240 GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG GLU SEQRES 7 A 240 GLU GLN TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU SEQRES 8 A 240 THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU TYR SEQRES 9 A 240 LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE SEQRES 10 A 240 GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU SEQRES 11 A 240 PRO GLN VAL TYR THR LEU PRO PRO SER ARG ASP GLU LEU SEQRES 12 A 240 THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY SEQRES 13 A 240 PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN SEQRES 14 A 240 GLY GLN PRO GLU ASN ASN TYR LYS ALA THR PRO PRO VAL SEQRES 15 A 240 LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU SEQRES 16 A 240 THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SEQRES 17 A 240 SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR SEQRES 18 A 240 THR GLN LYS SER LEU SER LEU SER PRO GLY GLY THR LYS SEQRES 19 A 240 HIS HIS HIS HIS HIS HIS SEQRES 1 B 240 GLY THR LYS SER CYS ASP LYS THR HIS THR CYS PRO PRO SEQRES 2 B 240 CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SER VAL PHE SEQRES 3 B 240 LEU PHE PRO PRO LYS PRO LYS ASP THR LEU MET ILE SER SEQRES 4 B 240 ARG THR PRO GLU VAL THR CYS VAL VAL VAL ASP VAL SER SEQRES 5 B 240 HIS GLU ASP PRO GLU VAL LYS PHE ASN TRP TYR VAL ASP SEQRES 6 B 240 GLY VAL GLU VAL HIS ASN ALA LYS THR LYS PRO ARG GLU SEQRES 7 B 240 GLU GLN TYR ASN SER THR TYR ARG VAL VAL SER VAL LEU SEQRES 8 B 240 THR VAL LEU HIS GLN ASP TRP LEU ASN GLY LYS GLU TYR SEQRES 9 B 240 LYS CYS LYS VAL SER ASN LYS ALA LEU PRO ALA PRO ILE SEQRES 10 B 240 GLU LYS THR ILE SER LYS ALA LYS GLY GLN PRO ARG GLU SEQRES 11 B 240 PRO GLN VAL TYR THR LEU PRO PRO SER ARG ASP GLU LEU SEQRES 12 B 240 THR LYS ASN GLN VAL SER LEU THR CYS LEU VAL LYS GLY SEQRES 13 B 240 PHE TYR PRO SER ASP ILE ALA VAL GLU TRP GLU SER ASN SEQRES 14 B 240 GLY GLN PRO GLU ASN ASN TYR LYS ALA THR PRO PRO VAL SEQRES 15 B 240 LEU ASP SER ASP GLY SER PHE PHE LEU TYR SER LYS LEU SEQRES 16 B 240 THR VAL ASP LYS SER ARG TRP GLN GLN GLY ASN VAL PHE SEQRES 17 B 240 SER CYS SER VAL MET HIS GLU ALA LEU HIS ASN HIS TYR SEQRES 18 B 240 THR GLN LYS SER LEU SER LEU SER PRO GLY GLY THR LYS SEQRES 19 B 240 HIS HIS HIS HIS HIS HIS MODRES 4ACP ASN B 297 ASN GLYCOSYLATION SITE HET NAG B1446 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 HOH *25(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 GLY A 316 1 8 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LYS B 360 5 7 HELIX 9 9 LYS B 414 GLN B 419 1 6 HELIX 10 10 LEU B 432 ASN B 434 5 3 SHEET 1 AA 4 SER A 239 PHE A 243 0 SHEET 2 AA 4 GLU A 258 VAL A 264 -1 O THR A 260 N PHE A 243 SHEET 3 AA 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 AA 4 GLU A 293 GLU A 294 1 O GLU A 293 N ARG A 301 SHEET 1 AB 4 SER A 239 PHE A 243 0 SHEET 2 AB 4 GLU A 258 VAL A 264 -1 O THR A 260 N PHE A 243 SHEET 3 AB 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 AB 4 LYS A 288 THR A 289 -1 O LYS A 288 N VAL A 305 SHEET 1 AC 2 GLU A 293 GLU A 294 0 SHEET 2 AC 2 TYR A 300 THR A 307 1 O ARG A 301 N GLU A 293 SHEET 1 AD 4 VAL A 282 VAL A 284 0 SHEET 2 AD 4 LYS A 274 VAL A 279 -1 O TRP A 277 N VAL A 284 SHEET 3 AD 4 TYR A 319 SER A 324 -1 O LYS A 320 N TYR A 278 SHEET 4 AD 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AE 4 GLN A 347 LEU A 351 0 SHEET 2 AE 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AE 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AE 4 VAL A 397 LEU A 398 1 O VAL A 397 N PHE A 405 SHEET 1 AF 4 GLN A 347 LEU A 351 0 SHEET 2 AF 4 GLN A 362 PHE A 372 -1 O THR A 366 N LEU A 351 SHEET 3 AF 4 PHE A 404 ASP A 413 -1 O PHE A 404 N PHE A 372 SHEET 4 AF 4 TYR A 391 ALA A 393 -1 O LYS A 392 N LYS A 409 SHEET 1 AG 2 VAL A 397 LEU A 398 0 SHEET 2 AG 2 PHE A 404 ASP A 413 1 O PHE A 405 N VAL A 397 SHEET 1 AH 4 GLN A 386 PRO A 387 0 SHEET 2 AH 4 ALA A 378 SER A 383 -1 O SER A 383 N GLN A 386 SHEET 3 AH 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 AH 4 THR A 437 LEU A 441 -1 O THR A 437 N VAL A 427 SHEET 1 BA 4 SER B 239 PHE B 243 0 SHEET 2 BA 4 GLU B 258 SER B 267 -1 O THR B 260 N PHE B 243 SHEET 3 BA 4 THR B 299 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BA 4 GLU B 293 GLN B 295 1 O GLU B 293 N ARG B 301 SHEET 1 BB 4 SER B 239 PHE B 243 0 SHEET 2 BB 4 GLU B 258 SER B 267 -1 O THR B 260 N PHE B 243 SHEET 3 BB 4 THR B 299 THR B 307 -1 O TYR B 300 N VAL B 266 SHEET 4 BB 4 LYS B 288 THR B 289 -1 O LYS B 288 N VAL B 305 SHEET 1 BC 2 GLU B 293 GLN B 295 0 SHEET 2 BC 2 THR B 299 THR B 307 1 O THR B 299 N GLN B 295 SHEET 1 BD 4 VAL B 282 VAL B 284 0 SHEET 2 BD 4 LYS B 274 VAL B 279 -1 O TRP B 277 N VAL B 284 SHEET 3 BD 4 TYR B 319 SER B 324 -1 O LYS B 320 N TYR B 278 SHEET 4 BD 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 BE 4 GLN B 347 LEU B 351 0 SHEET 2 BE 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BE 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BE 4 VAL B 397 LEU B 398 1 O VAL B 397 N PHE B 405 SHEET 1 BF 4 GLN B 347 LEU B 351 0 SHEET 2 BF 4 GLN B 362 PHE B 372 -1 O THR B 366 N LEU B 351 SHEET 3 BF 4 PHE B 404 ASP B 413 -1 O PHE B 404 N PHE B 372 SHEET 4 BF 4 TYR B 391 ALA B 393 -1 O LYS B 392 N LYS B 409 SHEET 1 BG 2 VAL B 397 LEU B 398 0 SHEET 2 BG 2 PHE B 404 ASP B 413 1 O PHE B 405 N VAL B 397 SHEET 1 BH 4 GLN B 386 PRO B 387 0 SHEET 2 BH 4 ALA B 378 SER B 383 -1 O SER B 383 N GLN B 386 SHEET 3 BH 4 PHE B 423 MET B 428 -1 O SER B 424 N GLU B 382 SHEET 4 BH 4 TYR B 436 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.07 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.04 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.04 LINK ND2 ASN B 297 C1 NAG B1446 1555 1555 1.44 CISPEP 1 TYR A 373 PRO A 374 0 -6.66 CISPEP 2 TYR B 373 PRO B 374 0 -12.07 CRYST1 69.290 110.857 77.508 90.00 107.92 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014432 0.000000 0.004667 0.00000 SCALE2 0.000000 0.009021 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013560 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -0.862632 -0.499578 -0.079291 -39.07106 1 MTRIX2 2 -0.497106 0.808281 0.315543 -17.14447 1 MTRIX3 2 -0.093549 0.311613 -0.945593 37.04609 1